• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,223.58 808.23
( 1.07%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Bacil Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524516
INE711D01018
18.6255138
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
102.31
74.89
EPS(TTM)
Face Value()
Div & Yield %
0.51
10
0
 
( Cr)
ParticularsMar 2026 ( Cr)Dec 2025 ( Cr)Sep 2025 ( Cr)
Gross Sales0.000.000.00
Other Operating Income0.000.000.00
Other Income 0.110.060.05
Total Income0.110.060.05
Total Expenditure 0.070.030.04
PBIDT0.040.040.02
Interest 0.000.000.00
PBDT0.040.040.02
Depreciation0.000.000.00
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.580.000.00
Reported Profit After Tax0.620.040.01
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item0.620.040.01
EPS (Unit Curr.)0.440.030.01
EPS (Adj) (Unit Curr.)0.440.030.01
Calculated EPS (Unit Curr.)0.440.030.01
Calculated EPS (Adj) (Unit Curr.)0.440.030.01
Calculated EPS (Ann.) (Unit Curr.)1.780.110.04
Calculated EPS (Adj) (Ann.) (Unit Curr.)1.780.110.04
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity13.9713.9713.97
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)0.000.000.00
PBDTM(%)0.000.000.00
PATM(%)0.000.000.00